Medium materiality6/10
Belite Bio, Inc, ADR (BLTE) PT Raised to $220 at Mizuho
Why it may matterVerify against the original reporting
Target raised; bullish setup.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BLTE received an analyst target update from Mizuho Securities.
- Target: 220; Posted price: 166.28; Firm: Mizuho Securities; Analyst: Graig Suvannavejh
Key facts
- 01
Target: $220
- 02
Posted price: $166.28
- 03
Analyst firm: Mizuho Securities
- 04
Analyst: Graig Suvannavejh
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.